Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Kidney International Reports|December 23, 2017
Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4Olivier Devuyst, Arlene B Chapman, Susan E Shoaf, et al.
The Journal of Biological Chemistry|April 2, 2005
Internal translation initiation mediated by the angiogenic factor Tie2Eun-Hee Park, Joseph M Lee, Jaime D Blais, et al.
Journal of Virology|November 16, 2004
Resistance to vesicular stomatitis virus infection requires a functional cross talk between the eukaryotic translation initiation factor 2alpha kinases PERK and PKRDionissios Baltzis, Li-Ke Qu, Stavroula Papadopoulou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2016
Prevalence of autosomal dominant polycystic kidney disease in the European UnionCynthia J Willey, Jaime D Blais, Anthony K Hall, et al.
Cancer Medicine|March 3, 2017
Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trialsRichard J Gralla, Fatima Ahmad, Jaime D Blais, et al.
Clinical Kidney Journal|February 13, 2019
Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney diseaseMarie E Edwards, Jaime D Blais, Frank S Czerwiec, et al.
The Journal of Biological Chemistry|April 6, 2006
Internal ribosome entry site-mediated translation of Apaf-1, but not XIAP, is regulated during UV-induced cell deathNicoleta Hosszu Ungureanu, Mireille Cloutier, Stephen M Lewis, et al.
Molecular and Cellular Biology|August 18, 2004
Activating transcription factor 4 is translationally regulated by hypoxic stressJaime D Blais, Vasilisa Filipenko, Meixia Bi, et al.
The Journal of Biological Chemistry|May 6, 2010
A small molecule inhibitor of endoplasmic reticulum oxidation 1 (ERO1) with selectively reversible thiol reactivityJaime D Blais, King-Tung Chin, Ester Zito, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 6, 2017
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 TrialVicente E Torres, Arlene B Chapman, Olivier Devuyst, et al.
Pageof 3